𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Contribution of Germline BRCA1 and BRCA2 Mutations to Familial Ovarian Cancer: No Evidence for Other Ovarian Cancer–Susceptibility Genes

✍ Scribed by Simon A. Gayther; Paul Russell; Patricia Harrington; Antonis C. Antoniou; Douglas F. Easton; Bruce A.J. Ponder

Book ID
117853005
Publisher
American Society of Human Genetics
Year
1999
Tongue
English
Weight
435 KB
Volume
65
Category
Article
ISSN
0002-9297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contribution of BRCA1 and BRCA2 mutation
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
✍ Susan J. Ramus; Patricia A. Harrington; Carole Pye; Richard A. DiCioccio; Mark J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

A total of 283 epithelial ovarian cancer families from the United Kingdom (UK) and the United States (US) were screened for coding sequence changes and large genomic alterations (rearrangements and deletions) in the BRCA1 and BRCA2 genes. Deleterious BRCA1 mutations were identified in 104 families (

Germline mutations of BRCA1 and BRCA2 in
Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families
✍ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2

Germline mutations in the BRCA1 and BRCA
Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients
✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w

Novel germline mutations in the BRCA1 an
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families
✍ Mani T. Valarmathi; Meenakshi Sawhney; Suryanarayana S. V. Deo; Nootan K. Shukla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo